Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors

US6114347A · kind A · utility

Assignees

• LTS Lohmann Therapie-Systeme AG · DE
• ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH · IL

Inventors

• Thomas Hille · Neuwied, DE
• Walter Muller · Neuwied, DE
• Bodo Asmussen · Bendorf, DE
• Aharon Levy · Beit Hanan, IL
• Yacov Meshulam · Ramat Gan, IL

Key dates

• Filing date: Aug 23, 1996
• Grant date: Sep 5, 2000
• Expiry date: Aug 23, 2016

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P39/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical formulation for the prophylaxis and preliminary treatment of a poisoning caused by organophosphorus cholinesterase inhibitors is characterized in that it consists of an active substance combination of at least one parasympathomimetic and at least one parasympatholytic.